| Literature DB >> 32260353 |
Kanokwan Kiwfo1,2,3, Wasin Wongwilai1,4, Tadao Sakai3, Norio Teshima3, Kate Grudpan1,2,4.
Abstract
A mono-segmented sequential injection lab-at-valve (SI-LAV) system for the determination of albumin, glucose, and creatinine, three key biomarkers in diabetes screening and diagnosis, was developed as a single system for multi-analyte analysis. The mono-segmentation technique was employed for in-line dilution, in-line single-standard calibration, and in-line standard addition. This made adjustments to the sample preparation step easy unlike the batch-wise method. The results showed that the system could be used for both fast reaction (albumin) and slow reaction (glucose with enzymatic reaction and creatinine). In the case of slow reaction, the analysis time could be shortened by using the reaction rate obtained with the SI-LAV system. This proposed system is for cost-effective and downscaling analysis, which would be applicable for small hospitals and clinics in remote places with a small number of samples but relatively fast screening would be needed.Entities:
Keywords: SI-LAV; albumin; creatinine; glucose; in-line dilution; in-line single-standard calibration; in-line standard addition; mono-segmented flow
Mesh:
Substances:
Year: 2020 PMID: 32260353 PMCID: PMC7180603 DOI: 10.3390/molecules25071666
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Usages of mono-segmentation in sequential injection analysis.
| No. | Analyte(s)/Sample (s) | Detection/Technique | Reagent | Role of Mono-Segmented | Ref. | ||
|---|---|---|---|---|---|---|---|
| Sample Conditioning (Inline Dilution) | Inline Single Std. Calibration | Inline Std. Addition | |||||
| 1 | Fe(II) in pharmaceutical preparations, | solution handing for spectrophotometric determination (Fe(II) and Cr(VI)) | KMnO4 for Fe(II) and diphenylcarbazide for Cr(VI) | X | [ | ||
| 2 | Fe(II) in anti-anemic medicine | spectrophotometric determination of Fe(II) | 1,10-phenanthroline | X | X | X | [ |
| 3 | sulfide in waters | spectrophotometric detection | Fe(III) and N,N-dimethyl-p-phenylene diamine hydrochloride | X | X | [ | |
| 4 | atrazine | voltammetric detection | X | X | [ | ||
| 5 | picloram in natural waters | voltammetric detection | X | X | [ | ||
| 6 | Mg, Ca in water sample | flame atomic absorption spectrometric detection | X | X | [ | ||
| 7 | methyl parathion in water sample | voltammetric detection | X | X | [ | ||
| 8 | Zn(II), Cd(II), Pb(II) and Cu(II) in water samples | voltammetric dectection | X | X | X | [ | |
| 9 | Al in water and beverage samples | tritrarion with spectrophotometric determination | sodium hydroxide as a titrant and phenolphthalein or thymolphthalein indicator | X | [ | ||
| 10 | benzoic acid in a real beverage sample | amperometric detection | biosensor is based on the inhibition effect of benzoic acid on the biocatalytic activity of tyrosinase, polyphenol oxidase. | X | X | X | [ |
| 11 | B in plants | spectrophotometric detection | azomethine-H | X | [ | ||
| 12 | Se (IV) in raw Se-enriched yeast | spectrophotometric detection | o-pheneylenediamine | X | X | [ | |
| 13 | Al in water and beverage samples. | spectrophotometric detection | Eriochrome cyanine R | X | X | [ | |
Figure 1Analytical signal obtained from albumin content in 200 µL (A) 0, (B) 2.1, (C) 3.5 µg human serum albumin (HSA).
Figure 2Analytical signal obtained from glucose content in 200 µL. (A) 0, (B) 2.4, and (C) 4 µg.
Figure 3A sequence profile for creatinine determination (R4: Mixed reagent for creatinine determination (R4: 0.025 mol·L–1 sodium picrate, 0.75% NaOH, 0.03 mol·L–1 KH2PO4), S: Pretreated creatinine solution).
Figure 4Analytical signal obtained from creatinine content in 200 µl (A) 0, (B) 10, and (C) 20 µg.
The determination of albumin, glucose, and creatinine in a urine sample *.
| Biomarker | Concentration (mg/dL) |
|---|---|
| Albumin | 1.8 |
| Glucose | not detectable ** |
| creatinine | 129 |
* A urine sample taken from a healthy female aged 31 years old; ** less than LOD as described earlier.
Figure 5Schematic diagram of the sequential injection lab-at-valve (SI-LAV).
Figure 6Operational sequences for (A) in-line sample dilution, (B) in-line single standard calibration, (C) in-line standard addition, W (DI water), S (sample), R (reagent), SD (standard solution).